logo

LSTA

Lisata Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

LSTA Profile

Lisata Therapeutics, Inc.

A clinical-stage pharmaceutical company that developing innovative therapies for advanced solid tumors

Biological Technology
Invalid Date
08/05/2013
NASDAQ Stock Exchange
26
12-31
Common stock
110 Allen Road, 2nd Floor, Basking Ridge, New Jersey 07920
--
Lisata Therapeutics, Inc., incorporated under the laws of the State of Delaware in the name of Fidelity Medical Services Ltd., was incorporated in September 1980 and commenced operations in the current market in January 2006. The Company is a clinical-stage pharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for the treatment of solid tumors and other critical diseases. The company's lead research candidate, LSTA 1 (formerly CEND-1), is designed to activate a new uptake pathway that enables combined-administered or bundled anticancer drugs to penetrate solid tumors more effectively.